Inflammation and Genomics in the Critical Care Unit

Critical Care Nursing Clinics of North America

Volumn 20, Issue 2, 2008, Pages 213-221

  Winkelman, Chris ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; COMPLEMENT; CYTOKINE; DEFENSIN; HISTAMINE; TOLL LIKE RECEPTOR;

BLOOD CLOTTING; CHROMOSOME MAP; CRITICAL ILLNESS; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; GENETICS; GENOMICS; HUMAN; INFLAMMATION; INTENSIVE CARE; METHODOLOGY; MOLECULAR BIOLOGY; NURSE ATTITUDE; NURSING ASSESSMENT; NURSING DISCIPLINE; PROTEOMICS; REVIEW; RISK ASSESSMENT;

ARACHIDONIC ACID; BLOOD COAGULATION; CHROMOSOME MAPPING; COMPLEMENT SYSTEM PROTEINS; CRITICAL CARE; CRITICAL ILLNESS; CYTOKINES; DEFENSINS; GENE EXPRESSION PROFILING; GENOMICS; HISTAMINE; HUMANS; INFLAMMATION; MOLECULAR BIOLOGY; NURSE'S ROLE; NURSING ASSESSMENT; PROTEOMICS; RISK ASSESSMENT; SPECIALTIES, NURSING; TOLL-LIKE RECEPTORS; VARIATION (GENETICS);

EID: 42049098847     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccell.2008.01.007     Document Type: Review

References (44)

1. Kumar V.K., Fausto N., and Abbas A. Robbins and Cotran pathologic basis of disease. 7th edition (2005), Saunders, Philadelphia p. 47, Chapter 2
2. Workman M.L. The cellular basis of bacterial infection. Crit Care Nurs Clin North Am 15 (2003) 1-11
3. Sorenson T.I., Nielson G.G., Andersen P.K., et al. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 318 (1988) 727-732
4. Lashley F.R. Clinical genetics in nursing practice. 3rd edition (2005), Springer, New York
5. Majetschack M., Flohe S., Obertacke U., et al. Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg 230 (1999) 207-214
6. Tang G.J., Huang S.L., Yien H.W., et al. Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 28 (2000) 2733-2736
7. Barber R.C., Chang L.Y., Arnoldo B.D., et al. Innate immunity SNPs are associated with risk for severe sepsis after burn injury. Clin Med Res 4 4 (2006) 250-255
8. McDaniel D.O., Hamilton J., Brock M., et al. Molecular analysis of inflammatory markers in trauma patients at risk of postinjury complications. J Trauma 63 1 (2007) 147-157
9. Stuber F., Klaschik S., Lehmann L.E., et al. Cytokine promoter polymorphisms in severe sepsis. Clin Infect Dis 41 Suppl 7 (2005) S416-S420
10. Clark M.F., and Baudouin S.V. A systematic review of the quality of genetic association studies in human sepsis. Intensive Care Med 32 (2006) 1706-1712
11. McDunn J.E., Chung T.P., Laramie J.M., et al. Physiologic genomics. Surgery 139 2 (2006) 133-139
12. van de Vijver M.J., He Y.D., van't Veer L.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347 25 (2002) 1999-2009
13. Sommers M.S. The cellular basis of septic shock. Crit Care Nurs Clin North Am 15 1 (2003) 13-25
14. Hanash S. Proteomics. Nature 22 (2003) 226-232
15. Knight P.R., Sreekumar A.S.., Siddiqui J., et al. Development of a sensitive microarray immunoassay and comparison with standard enzyme-linked immunoassay for cytokine analysis. Shock 21 (2004) 26-30
16. Chung T.P., Laramie J.M., Meyer D.J., et al. Molecular diagnostics in sepsis: from bench to bedside. J Am Coll Surg 203 (2006) 585-598
17. Prucha M., Moller E., Deogmer P., et al. Gene expression in septic patients manifests significant diagnostic signatures despite strong center-associated effects. Journal of Federation of European Biochemical Societies 272 s1 (2005) AbstractA4. p. 49
18. MacGlashan D. Histamine: a mediator of inflammation. J Allergy Clin Immunol 112 4 Suppl (2003) S53-S59
19. Ogawa Y., and Calhoun W.J. The role of leukotrienes in airway inflammation. J Allergy Clin Immunol 118 4 (2006) 789-798
20. Frank M.M. Hereditary angioedema: the clinical syndrome and its management in the United States. Immunol Allergy Clin North Am 26 4 (2006) 653-668
21. Chaplin D.D. Overview of the human immune response. J Allergy Clin Immunol 117 (2006) S430-S435
22. Morgan B.P., Marchbank K.J., Longhi M.P., et al. Complement: central to innate immunity and bridging to adaptive responses. Immunol Lett 97 (2005) 171-179
23. Tosi M.F. Innate immune responses to infection. J Allergy Clin Immunol 116 2 (2005) 241-249
24. Kapetanovic R., and Cavaillon J.M. Early events in innate immunity in the recognition of microbial pathogens. Expert Opin Biol Ther 7 6 (2007) 907-917
25. Short M.A., Schlichting D., and Qualy R.L. From bench to bedside: a review of the clinical trial development plan of drotrecogin alfa (activated). Curr Med Res Opin 22 12 (2006) 2525-2540
26. Hermans P.W.M., and Hazelzet J.A. Plasminogen activator inhibitor type 1 gene polymorphism and sepsis. Clin Infect Dis 41 (2005) S453-S458
27. Khanapure S.P., Garvey D.S., Janero D., et al. Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers. Curr Top Med Chem 7 3 (2007) 311-340
28. Ogawa Y., and Grant J.A. Mediators of anaphylaxis. Immunol Allergy Clin North Am 27 2 (2007) 249-260
29. Berger A. What are leukotrienes and how do they work in asthma?. Br Med J 319 (1999) 90
30. Corwin E.J. Understanding cytokines part II: implications for nursing research and practice. Biol Res Nurs 2 1 (2000) 41-48
31. Borish L., and Steinke J.W. Cytokines and chemokines. J Allergy Clin Immunol 111 2 Suppl (2003) S460-S475
32. Rubinstein M., Dinarello C.A., Oppenhiem J.J., et al. Recent advances in cytokine, cytokine receptors and signal transduction. Cytokine Growth Factor Rev 9 2 (1998) 175-181
33. Steinke J.W., and Borish L. Cytokines and chemokines. J Allergy Clin Immunol 117 2 (2006) S441-S445
34. Corwin E.J. Understanding cytokines part I: physiology and mechanism of action. Biol Res Nurs 2 1 (2000) 30-40
35. Giannoudis P.V. Current concepts of the inflammatory response after major trauma: an update. Injury 34 6 (2003) 397-404
36. Papathanassoglou E.D., Giannakopoulou M.D., and Bozas E. Genomic variations and susceptibility to sepsis. AACN Adv Crit Care 17 4 (2006) 394-422
37. Arcaroli J., Fessler M.B., and Abraham E. Genetic polymorphisms and sepsis. Shock 24 4 (2005) 300-312
38. Topel E.J., Smith J., Plow E.F., et al. Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet 15 Spec No 2 (2006) R117-R123
39. Renner P., Roger T., and Calandra T. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin Infect Dis 41 Suppl 7 (2005) S513-S519
40. Jawa R.S., Kulaylat M.N., Baumann H., et al. What is new in cytokine research related to trauma/critical care. Intensive Care Med 21 2 (2006) 63-85
41. Leaver S.K., Finney S.J., Burke-Gaffney A., et al. Sepsis since the discovery of Toll-like receptors: disease concepts and therapeutic opportunities. Crit Care Med 35 5 (2007) 1404-1410
42. Maizels R.M., and Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 3 9 (2003) 733-744
43. Sepkowitz KA. Concentric circles and knockout mice: Advances in TB detection, diagnosis and treatment. In: The Medscape Journal, 2000. Available at: http://www.medscape.com/viewarticle/418771. Accessed August 24, 2007.
44. NCBI. Molecular modeling: A method for unraveling protein structure and function. In: Just the Facts: A Basic Introduction to the Science Underlying NCBI Resources, 2004. Available at: http://www.ncbi.nlm.nih.gov/About/primer/molecularmod.html. Accessed September 1, 2007.